XFERALL, LLC – Trademark Portfolio
Entity Type: 16
XFERALL, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include X, XFERALL, and XFER+ALL PATIENT TRANSFERS. FOR ALL.. The owner is based in Austin, TX.
111 Congress Avenue, Suite 400
Austin, TX 78701
Showing of trademarks Trademarks
Trademark Classifications
XFERALL, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does XFERALL, LLC have?
XFERALL, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 1 abandoned.
What trademark classes does XFERALL, LLC file in?
XFERALL, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are XFERALL, LLC's most well-known trademarks?
XFERALL, LLC's registered trademark portfolio includes well-known marks such as X, XFERALL, and XFER+ALL PATIENT TRANSFERS. FOR ALL.. These are among 3 currently registered trademarks in the portfolio.
What is XFERALL, LLC's trademark registration success rate?
XFERALL, LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.